RSS   Newsletter   Contact   Advertise with us

Oxaco appoints two directors

Share on Twitter Share on LinkedIn
Staff writer | Begbroke, United Kingdom | September 16, 2015
OxacoSeptember 16, 2015, Begbroke, United Kingdom - Oxaco, a chemistry company, confirmed the appointment of Mark Warne as a non-executive director and Professor Lee Cronin as founding scientific director.
Mr. Warne is currently Head of Healthcare at IP Group plc. Mark has been with IP Group plc since 2008 developing and commercialising healthcare technology innovations primarily from research intensive universities. He currently represents IP Group plc on the boards of a number of its life science portfolio companies.

Mr. Warne joined IP Group plc from pre-clinical drug discovery contract research organisation, Exelgen, where he was managing director. He spent eight years at Exelgen (formerly Tripos Discovery Research) where he also held positions in licensing and strategic affairs, project management and research.

Mr. Warne has a PhD in Computational Chemistry, an MSc in Colloid Science and a BSc in Chemistry, all from the University of Bristol. Mark is a Chartered Chemist and member of the Royal Society of Chemistry.

Mr. Cronin is the Regius Chair of Chemistry in the Department Chemistry at the University. He was elected to the Fellowship of the Royal Society of Edinburgh, the Royal Society of Chemistry, and appointed to the Gardiner Chair in April 2009.

Mr. Cronin was awarded a Philip Leverhulme Prize by the Leverhulme Trust in 2007. He was awarded the Corday-Morgan medal of the Royal Society of Chemistry in 2012. He has published in excess of 300 peer-reviewed articles in a number of journals and has given over 280 invited presentations at conferences and universities worldwide.


 LATEST MOVES FROM United Kingdom 


MORE INSIDE POST